BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29705082)

  • 1. Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.
    Goya M; Nagashima M; Hiroshima KI; Hayashi K; Makihara Y; Fukunaga M; An Y; Ohe M; Sasaki T; Shiohira S; Shirai Y; Kawabata M; Ando K; Isobe M; Hirao K
    J Cardiol; 2018 Oct; 72(4):316-320. PubMed ID: 29705082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative outcomes of transvenous extraction of sprint fidelis and riata defibrillator leads: a single center experience.
    Richardson TD; Kolek MJ; Goyal SK; Shoemaker MB; Lewis AA; Rottman JN; Whalen SP; Ellis CR
    J Cardiovasc Electrophysiol; 2014 Jan; 25(1):36-42. PubMed ID: 24028661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter experience with extraction of the Riata/Riata ST ICD lead.
    Maytin M; Wilkoff BL; Brunner M; Cronin E; Love CJ; Grazia Bongiorni M; Segreti L; Carrillo RG; Garisto JD; Kutalek S; Subzposh F; Fischer A; Coffey JO; Gangireddy SR; Saba S; Mittal S; Arshad A; O'Keefe RM; Henrikson CA; Belott P; John RM; Epstein LM
    Heart Rhythm; 2014 Sep; 11(9):1613-8. PubMed ID: 24854215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.
    Ellis CR; Rottman JN
    Heart Rhythm; 2009 May; 6(5):619-24. PubMed ID: 19389648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased incidence of subacute lead perforation noted with one implantable cardioverter-defibrillator.
    Danik SB; Mansour M; Singh J; Reddy VY; Ellinor PT; Milan D; Heist EK; d'Avila A; Ruskin JN; Mela T
    Heart Rhythm; 2007 Apr; 4(4):439-42. PubMed ID: 17399630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparative Study of Defibrillator Leads at a Large-Volume Implanting Hospital: Results From the Pacemaker and Implantable Defibrillator Leads Survival Study ("PAIDLESS").
    Cohen TJ; Asheld WJ; Germano J; Islam S; Patel D
    J Invasive Cardiol; 2015 Jun; 27(6):292-300. PubMed ID: 26028656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal management of Riata leads with no known electrical abnormalities or externalization: a decision analysis.
    Pokorney SD; Zhou K; Matchar DB; Love S; Zeitler EP; Lewis R; Piccini JP
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):184-91. PubMed ID: 25311559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Canadian experience with Durata and Riata ST Optim defibrillator leads: a report from the Canadian Heart Rhythm Society Device Committee.
    Bennett MT; Ha AC; Exner DV; Tung SK; Parkash R; Connors S; Coutu B; Crystal E; Champagne J; Philippon F; Yee R; Stephenson EA; Nery PB; Essebag V; Sanatani S; Redfearn D; Krahn AD; Healey JS
    Heart Rhythm; 2013 Oct; 10(10):1478-81. PubMed ID: 23973950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse Generator Exchange Does Not Accelerate the Rate of Electrical Failure in a Recalled Small Caliber ICD Lead.
    Lovelock JD; Premkumar A; Levy MR; Mengistu A; Hoskins MH; El-Chami MF; Lloyd MS; Leon AR; Langberg JJ; Delurgio DB
    Pacing Clin Electrophysiol; 2015 Dec; 38(12):1434-8. PubMed ID: 26285670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on small-diameter implantable cardioverter-defibrillator leads performance.
    van Rees JB; van Welsenes GH; Borleffs CJ; Thijssen J; van der Velde ET; van der Wall EE; van Erven L; Schalij MJ
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):652-8. PubMed ID: 22352338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective nationwide fluoroscopic and electrical longitudinal follow-up of recalled Riata defibrillator leads in Denmark.
    Larsen JM; Nielsen JC; Johansen JB; Haarbo J; Petersen HH; Thøgersen AM; Hjortshøj SP
    Heart Rhythm; 2014 Dec; 11(12):2141-7. PubMed ID: 25008285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family.
    Hayashi K; Callahan T; Rickard J; Younis A; Baranowski B; Martin D; Nakhla S; Tabaja C; Wilkoff BL
    Europace; 2023 Dec; 25(12):. PubMed ID: 38000893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead implant duration does not always predict ease of extraction: extraction sheath may be required at < 1 year.
    Maytin M; Epstein LM; John RM
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1615-20. PubMed ID: 22017453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lead electrical parameters may not predict integrity of the Sprint Fidelis ICD lead.
    Maytin M; Epstein LM
    Heart Rhythm; 2012 Sep; 9(9):1446-51. PubMed ID: 22537883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of the Fidelis implantable cardioverter-defibrillator lead advisory: a report from the Canadian Heart Rhythm Society Device Advisory Committee.
    Krahn AD; Champagne J; Healey JS; Cameron D; Simpson CS; Thibault B; Mangat I; Tung S; Sterns L; Birnie DH; Exner DV; Parkash R; Sivakumaran S; Davies T; Coutu B; Crystal E; Wolfe K; Verma A; Stephenson EA; Sanatani S; Gow R; Connors S; Paredes FA; Essebag V;
    Heart Rhythm; 2008 May; 5(5):639-42. PubMed ID: 18452862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lead failure manifestation of Biotronik Linox with St. Jude Medical Riata and Medtronic Sprint Fidelis lead.
    Lam A; Buehler S; Goulouti E; Sweda R; Haeberlin A; Medeiros-Domingo A; Servatius H; Seiler J; Baldinger S; Noti F; Tanner H; Roten L
    J Interv Card Electrophysiol; 2019 Mar; 54(2):161-170. PubMed ID: 30471050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major predictors of fibrous adherences in transvenous implantable cardioverter-defibrillator lead extraction.
    Segreti L; Di Cori A; Soldati E; Zucchelli G; Viani S; Paperini L; De Lucia R; Coluccia G; Valsecchi S; Bongiorni MG
    Heart Rhythm; 2014 Dec; 11(12):2196-201. PubMed ID: 25111324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the transvenous extraction of cardioverter-defibrillator leads more hazardous than that of pacemaker leads?
    Małecka B; Kutarski A; Grabowski M
    Kardiol Pol; 2010 Aug; 68(8):884-90. PubMed ID: 20730717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-institutional study of implantable defibrillator lead performance in children and young adults: results of the Pediatric Lead Extractability and Survival Evaluation (PLEASE) study.
    Atallah J; Erickson CC; Cecchin F; Dubin AM; Law IH; Cohen MI; Lapage MJ; Cannon BC; Chun TU; Freedenberg V; Gierdalski M; Berul CI;
    Circulation; 2013 Jun; 127(24):2393-402. PubMed ID: 23694966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.